Clinical Trials Directory

Trials / Completed

CompletedNCT00645112

A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
357 (actual)
Sponsor
Abbott · Industry
Sex
All
Age
6 Months – 6 Years
Healthy volunteers
Not accepted

Summary

To compare the safety and efficacy of cefdinir oral suspension, 7 mg/kg every 12 hours for 5 days, to azithromycin oral suspension 10 mg/kg/day (Day 1) then 5 mg/kg/day (Days 2-5) for a total of 5 days, in children between 6 months and 6 years of age, with AOM.

Conditions

Interventions

TypeNameDescription
DRUGcefdinir (Omnicef)oral suspension, 7 mg/kg every 12 hours for 5 days
DRUGazithromycinoral suspension 10 mg/kg QD on Day 1 then 5 mg/kg QD on Days 2-5 for a total of 5 days.

Timeline

Start date
2003-11-01
Primary completion
2004-01-01
First posted
2008-03-27
Last updated
2008-03-27

Locations

30 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00645112. Inclusion in this directory is not an endorsement.

A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Oti (NCT00645112) · Clinical Trials Directory